Gräber, S. Y., Scheuermann, H., Hirtz, S., Mairbäurl, H., & Mall, M. A. (2018). Effects of Lumacaftor-Ivacaftor Therapy on Cystic Fibrosis Transmembrane Conductance Regulator Function in Phe508del Homozygous Patients with Cystic Fibrosis. American journal of respiratory and critical care medicine, 197(11), . https://doi.org/10.1164/rccm.201710-1983OC
Chicago Style (17th ed.) CitationGräber, Simon Y., Heike Scheuermann, Stephanie Hirtz, Heimo Mairbäurl, and Marcus A. Mall. "Effects of Lumacaftor-Ivacaftor Therapy on Cystic Fibrosis Transmembrane Conductance Regulator Function in Phe508del Homozygous Patients with Cystic Fibrosis." American Journal of Respiratory and Critical Care Medicine 197, no. 11 (2018). https://doi.org/10.1164/rccm.201710-1983OC.
MLA (9th ed.) CitationGräber, Simon Y., et al. "Effects of Lumacaftor-Ivacaftor Therapy on Cystic Fibrosis Transmembrane Conductance Regulator Function in Phe508del Homozygous Patients with Cystic Fibrosis." American Journal of Respiratory and Critical Care Medicine, vol. 197, no. 11, 2018, https://doi.org/10.1164/rccm.201710-1983OC.